Publications by authors named "Ron Sabo"

Claim this Profile
T
Transmission of heat modes across a potential barrier.
Amir Rosenblatt, Fabien Lafont, Ivan Levkivskyi, Ron Sabo, Itamar Gurman

Nat Commun· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of aliskiren/hydrochlorothiazide single-pill combination tablets and free combination of aliskiren and hydrochlorothiazide.
Jing-He Yan, Venkateswar Jarugula, Ron Sabo, Cheraz Cherif Papst, Jack Zhang

J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes.
Yan-Ling He, Ron Sabo, Franck Picard, Yibin Wang, Jerry Herron

Curr Med Res Opin· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers.
Yan-Ling He, Ron Sabo, Joelle Campestrini, Yibin Wang, Gilles-Jacques Riviere

Br J Clin Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
Yan-Ling He, Monica Ligueros-Saylan, Gangadhar Sunkara, Ron Sabo, Charlie Zhao

J Clin Pharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
Yan-Ling He, Brian M Sadler, Ron Sabo, Sebastien Balez, Yibin Wang

Clin Pharmacokinet· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose proportionality and the effect of food on vildagliptin, a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.
Gangadhar Sunkara, Ron Sabo, Yibin Wang, Yan-Ling He, Joelle Campestrini

J Clin Pharmacol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pharmacokinetic interactions between vildagliptin and digoxin in healthy volunteers.
Yan-Ling He, Ron Sabo, Gangadhar Sunkara, Marie-Noëlle Bizot, Gilles-Jacques Riviere

J Clin Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Yan-Ling He, Ron Sabo, Gilles-Jacques Riviere, Gangadhar Sunkara, Selene Leon

Curr Med Res Opin· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis